Preparation of wogonin liposomes and its pharmacokinetics in rats

Journal of China Pharmaceutical University

Volumn 38, Issue 6, 2007, Pages 502-506

  Ke, Xue ^a   Xu, Ying ^a   Yan, Fei ^a   Ping, Qi Neng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

In vitro release; Liposomes; Phamacokinetics; Wogonin

Indexed keywords

LIPOSOME; WOGONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; ENCAPSULATION; GEL FILTRATION CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; PH; RAT; SUSTAINED DRUG RELEASE;

EID: 37849029928     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Mora A, Paya M, Rios JL, et al. Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymatic lipid peroxidatio[J]. Biochem Pharmacol, 1990, 40(4): 793-797.
2. Oka H, Yamamoto S, Kuroki T, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9) [J]. Cancer, 1995, 76(5): 743-749.
3. Ping QN. 2001: 588-590.
4. Paola C, Maurizio C, Paola B, et al. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes [J]. J Control Release, 2000, 63(1-2): 19-30.
5. Xu Y, Ke X, Ping QN. Pharm Clin Res, 2007, 15(1): 35-38.
6. Lu B. China Pharm, 1998, 1(1): 20-22.
7. Chinese source.
8. Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms [J]. J Pharm Sci, 1967, 56 (10): 1 238-1 242.
9. Yu BT, Zhang ZR, Zeng RJ, Med J Southwest Natl Def, 2005, 15(6): 686-688.